Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is a publicly traded Financial Services sector company. As of July 21, 2026, DMAA trades at $10.69 with a market cap of $259.03M and a P/E ratio of 0.00. DMAA moved +0.00% today. Year to date, DMAA is +3.58%; over the trailing twelve months it is +5.21%. Its 52-week range spans $9.95 to $10.70. Rallies surfaces DMAA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for DMAA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $10.69 |
| Market Cap | $259.03M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.70 |
| 52-Week Low | $9.95 |
| Volume | 11 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $5.94M |
| Gross Margin | 0.00% |
DMAA analyst coverage data. Average price target: $0.00.